Original Contributions |
From Vanderbilt University School of Medicine, Departments of Medicine and Pharmacology, Nashville, Tenn.
| Abstract |
|---|
|
|
|---|
subunits are expressed alone (immature) or with the ß1
subunit (mature). In the present experiments, we tested the
hypothesis that suppression of ß1-subunit expression by
antisense oligonucleotides would prevent the
development of a mature INa. The mouse
ß1 subunit was cloned from an AT-1 cDNA library and found
to be identical to that in the rat at 216/218 amino acids. AT-1 cells
exposed to anti-ß1 antisense
oligonucleotides displayed an immature
INa at day 8 in culture, whereas untreated
cells or cells exposed to sense oligonucleotides
displayed a mature INa. This result was
observed with 2 different oligonucleotides, and neither
affected the rapidly activating component of the delayed rectifier
K+ current, another current recorded in AT-1 cells.
These findings indicate that in these cells, the gating of
INa is modulated by ß1
expression and that
-ß1 coexpression is required for
the development of a mature cardiac INa
phenotype.
Key Words: Na+ current ß subunit myocyte
| Introduction |
|---|
|
|
|---|
We have reported a very similar maturation process when INa in AT-1 cells is compared after 3 and after >7 days in culture.3 AT-1 cells were originally isolated from atrial tumors arising in mice carrying a transgene in which the atrial natriuretic factor promoter drove expression of the SV40 large-T antigen.4 As we and others have previously reported, AT-1 cells exhibit biochemical, histological, and electrophysiological properties very similar to those of mouse atrial myocytes.5 6 7 8 We found that INa in cells cultured for 3 days is smaller and activates and inactivates much more slowly than INa recorded in cells cultured for 10 days.3 The voltage dependence of activation was similar at the 2 time points, but the voltage dependence of inactivation was, as in the rat myocyte experiments, less negative in the 3-day cells. In cells cultured from days 0 to 3 in medium containing CPT cAMP, a mature INa phenotype was observed, with a greater amplitude, more rapid activation, and more negative voltage dependence of inactivation than in 3-day control cells.
The differences between INa in AT-1 cells
at 3 and 10 days in culture or between that recorded in neonatal
and in adult rat myocytes are reminiscent of the differences observed
when Na+ channel
subunits are expressed with
and without the ancillary ß1 subunit: Isom et
al9 reported that coexpression of
ß1 with rat brain
subunits in
Xenopus oocytes resulted in INa
that was larger, activated and inactivated more
rapidly, and displayed voltage dependence of inactivation that was more
negative than that observed when the
subunit alone was expressed.
As discussed further below, the extent to which
ß1 modulates the function of expressed cardiac
subunits in Xenopus oocytes is controversial, and the
extent to which the experiments in oocytes reflect information obtained
in mammalian systems is uncertain. We hypothesized that the
phenotype switch that we and others have observed in maturing
INa was attributable to an
-ß1 interaction in cardiac myocytes. In the
present set of experiments, we tested this hypothesis with the use
of antisense oligonucleotides targeting
ß1 expression in AT-1 cells. Portions of the
present study have been reported previously in abstract
form.10
| Materials and Methods |
|---|
|
|
|---|
gt10 (a gift of Dr Mike Tamkun, Colorado State University, Fort
Collins, Colo) were screened under low-stringency conditions (20%
formamide, 42°C) using the rat Na+ channel
ß1-subunit cDNA as a probe (a gift of Dr Al
George, Vanderbilt University School of Medicine, Nashville,
Tenn). Library screening was performed according to standard
methods11 with 3 rounds of plaque purification.
Probes were labeled using the Prime-It II kit (Stratagene) and
[
-32P]dATP (NEN). DNA of positive phage
clones was prepared using the Wizard Lambda Prep DNA purification
system (Promega), and inserts were released via EcoRI
digestion followed by subcloning into the EcoRI site of
pBluescript KS- (Stratagene). Sequencing was
performed partly by manual sequencing using Sequenase 2.0 (USB) and
partly by using an automated sequencer (model 373A, Applied
Biosystems). The mouse Na+ channel
ß1-subunit sequence has been deposited in
GenBank under accession No. U85786.
RNase Protection
A polymerase chain reaction (PCR) fragment consisting of
nucleotides 1 to 360 of the mouse
ß1 subunit was subcloned into the PCR II vector
(Invitrogen). In the present study, numbering starts at the initial
adenine at the putative translation start codon. The orientation of the
insert was established by sequencing. The plasmid was linearized by
digestion at the 5' end of the insert with XhoI. From this
template, an RNase protection probe was generated by performing in
vitro transcription using Sp6 RNA polymerase in a 10-µL reaction
containing a final concentration of 1x the manufacturer's
transcription buffer, 500 µmol/L each of unlabeled ATP, CTP, and
GTP, 10 µmol/L unlabeled UTP, and 40 µCi
[
-32P]UTP. The reaction was allowed to
proceed for 60 minutes at 37°C and was terminated by incubation for a
further 20 minutes with RNase-free DNase I to remove the template DNA.
The resulting radiolabeled RNA was purified of unincorporated
nucleotides and protein by passage through a QIAquick PCR
purification column (QIAGEN Inc). This radiolabeled probe RNA was then
made up in hybridization buffer (80% formamide, 40 mmol/L PIPES,
pH 6.4, 400 mmol/L NaCl, and 1 mmol/L EDTA) and retained for
use in the hybridization reaction.
Total RNA was isolated from tissue or from AT-1 cells growing in
culture using the acid phenol method.12 For the
hybridization reaction, 10 µg of target RNA and 10 µg of yeast tRNA
(as a neutral carrier) were mixed with
500 000 cpm of the
radiolabeled probe RNA. The total volume of the hybridization was made
up to 30 µL with hybridization buffer. The mixture was heated to
85°C and then slowly cooled to 45°C overnight. Control reactions
with no target RNA and 20 µg of yeast tRNA were run to allow
differentiation of the bands that result from hybridization of the
probe RNA to the target RNA from those that result from secondary
structures in the probe RNA. After the hybridization was complete, 350
µL of RNase digestion buffer (10 mmol/L Tris, pH 7.5, 300
mmol/L NaCl, and 5 mmol/L EDTA) containing RNase A (30 µg/mL)
was added to each hybridization and incubated at 30°C for 45 minutes.
Digestion was terminated by adding SDS to a final concentration of
0.5% (wt/vol) and proteinase K to a final concentration of 250 µg/mL
and by incubation at 37°C for 45 minutes. The mixture was then
phenol-extracted, ethanol-precipitated, and made up in loading buffer
(46% formamide, 0.125% bromphenol blue, 0.125% xylene cyanole, and
0.25x TBE). The samples were denatured by heating to 85°C and then
run on a 4% denaturing polyacrylamide gel. Dried gels were
exposed to film, and quantitative analysis of the bands was
accomplished using a PhosphorImager (Molecular Dynamics).
AT-1 Cell Preparation
As previously described,3 cells obtained
from Loren Field (Krannert Institute) were injected subcutaneously into
new syngeneic hosts ([C57BL/6JxDBA/2J]F1
female mice, Jackson Laboratories, Bar Harbor, Me). In 6 to 8 weeks,
subcutaneous tumors became palpable, and cells were isolated 12 to 16
weeks after inoculation. With each cell isolation, further syngeneic
hosts were inoculated to propagate the colony. To isolate cells,
tumor-bearing mice were anesthetized with isoflurane (Abbott
Laboratories) and placed in 70% ethanol. The tumor mass was
excised, rinsed with PBS, minced finely, and placed for 1 hour at
37°C with gentle rocking in PBS containing 100 U/mL penicillin and
100 µg/mL streptomycin (pen-strep, GIBCO) and 0.1%
collagenase. The cell suspension was spun, washed with PBS,
resuspended, and then plated at a density of 250 to
325x103 cells/mL in 100-mm Primaria dishes
(Falcon). The media (PC1 [Ventrex Laboratories], which included
pen-strep, 10% FBS, and 10 nmol/L dexamethasone) were
changed every other day until used. Primary cultures grew to confluence
and usually beat spontaneously at
1 week. It has been reported by
others5 that isolated cells can also be
repassaged or frozen for subsequent replating, but this approach was
not used in these experiments. For
electrophysiological studies, cells were
removed from the culture dish by a 2-minute exposure to a
trypsin-containing solution (0.125% in Ca2+- and
Mg2+-free Hanks' solution), decanted into
sterile culture tubes, and held at room temperature. Parallel control
experiments were performed to study the effects of interventions: in
each case, cells from an individual tumor isolation were cultured in
multiple dishes, and untreated and treated cells were isolated and
studied on the same day.
Two different pairs of oligonucleotides, both targeting the region surrounding the 5' ATG translation start site, were tested. The antisense oligonucleotides were complementary to nucleotides 21 to 5 (designated #1) and nucleotides 4 to -11 (designated #2). The antisense oligonucleotides and the corresponding sense oligonucleotides were synthesized by a core facility at our institution. To assess whether the antisense oligonucleotide effect was INa specific, we also determined the effect of anti-ß1 oligonucleotides on another current we routinely observe in AT-1 cells, the rapidly activating component of the delayed rectifier K+ current (IKr).8 As described below (Results), cells were studied on day 8 (after exposure to oligonucleotide on days 0 to 8 in culture) and on day 14 (after exposure to oligonucleotide on days 10 to 14). With each culture medium change (every 48 hours), fresh oligonucleotide (1 µmol/L) was added to the culture medium. Data were then obtained by studying sense-exposed and antisense-exposed cells on the same day.
Electrophysiological Recording
Whole-cell recordings were performed using an
Axopatch-200A patch-clamp amplifier (Axon Instruments, Inc).
Microelectrodes were pulled from borosilicate glass (Fisher Scientific)
and heat-polished. The recording temperature was 18°C. The
currents were low passfiltered at 5 to 10 kHz (Bessel filter, -3
dB), sampled at 25 kHz, and stored on hard disk for subsequent
analysis. Data acquisition and command potentials were
controlled with a commercial software program (pClamp6.0, Axon
Instruments). Microelectrode tip resistance was
1 M
(0.8±0.3
M
, n=30). Junction potential was zeroed with a reference electrode
into the standard bathing solution. Microelectrodes were gently lowered
onto the cell surface, and gigaohm seal formation was achieved by
suction (range, 5 to 50 G
). After the whole-cell configuration was
established, the capacitive transients elicited by symmetrical 10-mV
voltage-clamp steps from -80 mV were recorded at 50 kHz (filtered
at a bandwidth of 10 kHz, -3 dB) for calculation of capacitive surface
area, time constant, and access resistance. Thereafter, capacitance and
series resistance compensation were optimized;
80% compensation was
usually obtained. All currents were normalized to cell size, which was
determined by recording the capacitative current (after
compensation) elicited by a voltage clamp step from -80 to -90 mV.
Individual cell capacitance was then calculated as
Q/
V=
Idt/
V=
Idt/10, where Q is
charge, V is voltage, and I is current.
To measure INa, the pipette-filling solution contained (mmol/L) NaF 10, CsF 110, CsCl 20, EGTA 10, and HEPES 10, and the pH of the solution was adjusted to 7.35 with CsOH. The external K+-free solution contained (mmol/L) NaCl 20, CsCl 110, MgCl2 1, CaCl2 0.1, tetraethylammonium chloride 5, HEPES 10, NiCl2 0.2 (to block T-type Ca2+ currents), nisoldipine (to block L-type Ca2+ currents) 1 µmol/L, and glucose 10, and the pH of the solution was adjusted to 7.35 with CsOH. A pulse duration of 60 milliseconds from a holding potential of -120 mV was used to assess INa activation, and variable holding potentials with a test pulse to -30 mV were used to assess inactivation; pulses were delivered every 5 seconds. Peak INa was measured within a moving time window beyond capacitive transients.
To record IKr, the extracellular
solution was normal Tyrode's solution containing (mmol/L) NaCl 130,
KCl 4, CaCl2 1.8, MgCl2 1,
HEPES 10, and glucose 10, with the pH adjusted to 7.35 with NaOH. The
intracellular pipette-filling solution contained (mmol/L) KCl 110,
K4BAPTA 5, K2ATP 5,
MgCl2 1, and HEPES 10, and the solution was
adjusted to pH 7.2 with KOH, yielding a final intracellular
K+ concentration of
145 mmol/L. Pulses of
1-second duration to a range of depolarizing potentials (-30 to +50
mV) from a holding potential of -40 mV were used; tail currents were
measured as the difference between current recorded immediately
after a step back to -40 mV and holding current at -40 mV. Chemicals
were obtained from Sigma Chemical Co. Nisoldipine was obtained from
Miles Pharmaceutical, Inc.
Data Analysis
The voltage dependence of channel opening and inactivation was
determined by fitting a Boltzmann function,
y=1/(1+exp[-(V-V1/2)/k]), to activation or
inactivation curves, where k represents the slope factor, and
V1/2 indicates the voltage at which 50% of the
channels were activated or inactivated.
Inactivation was fit with monoexponential or
biexponential functions; the choice between the 2 functions was made
using goodness-of-fit criteria as in previous
work.13 With depolarizing pulses to -30 mV, the
"mature" phenotype is characterized by large currents (>20
pA/pF at -30 mV), biexponential inactivation with a slow time constant
(
slow,
15 milliseconds), and a time to peak
of <5 milliseconds; in addition, the V1/2 for
inactivation is negative to -80 mV.3 By
contrast, the "immature" INa is smaller
(<15 pA/pF), inactivates more slowly and in a
monoexponential fashion (
slow,
14 milliseconds), and activates more slowly (time to peak,
>8 milliseconds); the V1/2 for inactivation is
generally positive to -80 mV.
Data are presented as mean±1 SE. For comparisons among means of several treatment groups, ANOVA was used, with post hoc pairwise comparisons by the Duncan test if significant differences among means were detected. If only 2 groups were being compared, the Student t test was used. A value of P<0.05 was considered significant.
| Results |
|---|
|
|
|---|
Our previous studies had demonstrated that the
INa phenotype switch in AT-1 cells
occurred by day 7 in culture.3 Therefore, to
determine whether anti-ß1 antisense prevented
this change in phenotype, we assessed the effect of exposing
cells to sense or to antisense oligonucleotides from
day 0 to day 8 in culture, and INa was
studied on day 8. INa recorded from
AT-1 cells exposed to sense or to antisense
oligonucleotide is presented in Figure 1
. INa in
antisense-treated cells activated and inactivated
more slowly than did INa in untreated
control or sense-treated cells. As shown in Figure 2
, this reduction in
INa amplitude was observed with both
antisense oligonucleotides used, but not with the
corresponding sense oligonucleotides. The voltage
dependence of activation was no different in antisense-treated cells
compared with in sense-treated (or control untreated) cells (Figure 3A
), and the slope factors were similar
(antisense, 5.1±0.4 mV; sense, 4.8±0.4 mV; and untreated, 5.5±0.6
mV). However, the voltage dependence of inactivation was more positive
in the antisense-treated cells (Figure 3B
), although again the slope
factors were similar (antisense, 8.3±0.6 mV; sense, 7.3±0.2 mV; and
untreated, 6.6±0.2 mV). A summary of the
electrophysiological characteristics of
INa recorded at day 8 in sense-exposed
and antisense-exposed cells is presented in the
Table
, along with a summary of data
we3 have previously reported on
INa at day 3 (immature phenotype)
and at day 14 (mature phenotype). Antisense-exposed cells
demonstrated all the characteristics of immature
INa at 3 days, including decreased current
amplitude, prolonged time to peak, monoexponential and
slow inactivation, and less negative voltage dependence of
inactivation. In addition, as shown in Figure 4
, recovery from inactivation was slower
in cells studied at day 3 versus day 10 in culture (left) and in
antisense-exposed cells versus sense-exposed cells (right).
|
|
|
|
|
In our previous studies,3 we demonstrated that
the mature INa phenotype could be
reverted to the immature one by exposure of cells from days 10 to 14 to
the cAMP inhibitor Rp-cAMPS. Therefore, we undertook
experiments in which AT-1 cells at 10 days in culture were exposed to
anti-ß1 sense or antisense
oligonucleotide from day 10 to day 14. As shown in the
Table
, antisense exposure from day 10 to day 14 restored the immature
INa phenotype.
To guard against the possibility of nonspecific antisense results, 2
different oligonucleotides were tested in these
experiments (Figure 2
), and the results with both were similar. In
addition, another current in AT-1 cells,
IKr, was virtually indistinguishable in
antisense-treated cells compared with sense-treated cells. The maximum
tail current amplitudes were 3.5±0.1 (antisense-exposed) versus
3.4±0.1 pA/pF (sense-exposed) (n=6 each), the midpoints for
IKr activation were -0.7±0.3 and 4.6±0.3
mV, respectively, and the slope factors were 10
mV-1 in both cases.
RNase protection was used to determine whether
anti-ß1 antisense exerted its effects by
altering steady-state mRNA abundance. As shown in Figure 5
, mRNA abundance, normalized to rat
cyclophilin, was unaltered in antisense-exposed cells compared with
sense-exposed and with unexposed cells; this result was replicated 3
times with the use of both oligonucleotide pairs. As
discussed further below, this result indicates that the effect of
anti-ß1 antisense was likely mediated via a
decrease in ß1 protein (or other
posttranslational effects) rather than altered mRNA stability or
decreased ß1 gene transcription.
|
| Discussion |
|---|
|
|
|---|
-ß1 interaction plays a critical role in
this maturation process.
Function of ß1 Subunits
When brain or skeletal muscle INa
subunits are coexpressed with the ß1 subunit in
Xenopus oocytes, the physiological
behavior of the resultant INa is markedly
altered: activation and inactivation are more rapid, recovery from
inactivation is accelerated, and the current is
larger.9 Although Na+
channel ß1 mRNA is detected in
heart,14 15 it has been controversial whether
ß1 modulates the function of cardiac
INa. In coexpression studies in
Xenopus oocytes, one group has reported no change in
phenotype,14 another group has reported
an increase in current amplitude as the major
effect,15 and a third group has reported effects
of ß1 on the human cardiac
subunit that are
similar to those with the brain
subunit.16
More recently, a role for both ß1 and
ß2 subunits in channel localization has been
proposed on the basis of the inferred immunoglobulin-like extracellular
domains of the proteins.17 In addition, Isom et
al18 have shown that (in contrast to data
obtained in ooyctes) expression of brain
subunits in Chinese
hamster ovary cells results in a rapidly activating and inactivating
current. One possible explanation for this result could be the presence
of an endogenous ß1 subunit in
these cells, but such a subunit was not found, implying that normal
gating could be observed with expression of the brain
subunit alone
in a mammalian cell line. In the Chinese hamster ovary cell studies,
the major effect of
+ß1 coexpression was to
increase INa amplitude. In addition, the
voltage dependence of inactivation was more negative, reminiscent of
the effect of the maturation that we and others have observed in
myocytes in culture (Figure 3B
).
Our data strongly suggest that an
-ß1
interaction occurs during development and is responsible for the
maturation of the cardiac INa. Moreover,
our data indicate that an immature phenotype can be restored to
a mature INa, eg, by Rp-cAMPS or by
anti-ß1 antisense intervention. This further
raises the possibility that in disease, INa
function may become abnormal in part because of loss of association of
an important ß1 subunit. We speculate that the
result of such a loss would include a smaller
INa as well as a shift of inactivation to
more positive potentials. With the exception of Lue and
Boyden,19 who found a smaller
INa but a negative shift in inactivation in
cells that had been subjected to a recent ischemic insult,
systematic studies of the effects of heart disease on
INa have not been conducted. As noted
above, Zhang et al1 reported that
INa in neonatal rat cells was smaller and
activated and inactivated more slowly than that in
adult cells; in their studies, inactivation was also shifted more
negatively in the adult cells, similar to our findings.
Antisense Inhibition of Ion Currents in Excitable Cells
We and others have previously shown that exposure of cultured
excitable cells to oligonucleotides targeting ion
channel subunits can reduce ion current. When cultured human atrial
myocytes were exposed to anti-Kv1.5 antisense
oligonucleotides,20 the amplitude
of the ultrarapid delayed rectifier K+ current
was reduced, lending very strong support to the idea that Kv1.5 encodes
the major
subunit for this current. Similarly, anti-Kv1.5
oligonucleotides reduced the delayed rectifier current
in cultured glial cells21 and in cultured
pituitary cells.22 In the latter experiments,
oligonucleotides targeting Kv1.4 were shown to reduce
transient outward current, implicating Kv1.4 as a gene encoding a
transient outwardlike current in these cells. Likewise,
oligonucleotides targeting the cystic fibrosis
transmembrane conductance regulator were found to reduce
cAMP-activated Cl- current in cultured
epithelial cells.23 Our finding that
anti-minK oligonucleotides reduced the
amplitude of IKr in AT-1
cells24 suggested an interaction between
minK and HERG, the gene encoding the major
subunit underlying IKr. This concept has
been supported by recent work from others25 that
coexpression of minK and HERG resulted in larger
IKr than did expression of HERG
alone in transfected mammalian cells; moreover, evidence for physical
association between the 2 proteins was presented.
To ensure that the effect of antisense treatment is specific, most
previous studies have, like the experiments reported in the present
study, used controls (sense and/or random
oligonucleotides) and have tested more than one
antisense-sense pair. The mechanisms whereby antisense
oligonucleotides inhibit protein function are not
certain. One possibility is that binding of
oligonucleotide to mRNA destabilizes the mRNA or that
the oligonucleotide prevents gene
transcription.26 27 Either case would result in a
decrease in steady-state mRNA abundance, but not all previous studies
have examined this question; among the studies that have,
some23 but not all24
observed the effect. An alternate explanation for the
inhibitory effect of antisense
oligonucleotides is inhibition of translation by
oligonucleotide binding to mRNA. In this case, mRNA
abundance would be unaltered, but functional effects would nevertheless
be observed. Demonstration of decreased protein
abundance23 can be used to support this idea. We
did obtain polyclonal anti-ß1 antibodies for
such experiments (courtesy of William Catterall and Brian Murphy at the
University of Washington, Seattle) but were unable to demonstrate
immunoreactive ß1 protein in the cells; we
assume that this represents low basal expression of the protein
in these cells. Finally, it is possible that antisense
oligonucleotides produce their effects through
mechanisms that are nonspecific or at least unrelated to inhibition of
gene transcription or mRNA translation, eg, by directly inhibiting ion
permeation or
-ß1 interactions. We consider
this unlikely since the effect was seen with 2 sense-antisense pairs
and did not affect the function of another ion current present in
these cells.
Can the Phenotype Switch Be Explained by Expression of
Multiple
Subunits?
In our previous experiments in AT-1 cells, we found that the
sensitivity of INa to tetrodotoxin was
similar (EC50, 100 to 200 nmol/L) at the 2 time
points. Since this EC50 value is typical of
neither neuronal (EC50, <10 nmol/L) nor cardiac
(EC50, generally >1 µmol/L)
subunits,
we raised the possibility that multiple
subunits were present.
The present findings, by indicating that the
INa phenotype is dependent on
ß1 expression, argue that variability in
expression of different
subunits is not the mechanism underlying
the change in INa phenotype. Also
arguing against this possibility is the finding by Zhang et
al1 that the unitary conductance of
INa was similar at the 2 time points. In
addition, the tetrodotoxin sensitivity was similar at the 2 time points
(despite a difference in phenotype), arguing against multiple
subunits. When we performed Northern analysis using 14-day
AT-1 cell mRNA and a probe derived from an isoform-specific region (the
DII-III linker) of the rat cardiac Na+ channel
gene, we found only a single band (data not shown). These findings
collectively argue against the expression of multiple
Na+ channel isoforms as the mechanism underlying
the change in INa that we and others have
reported here and previously.1 2 3 We recognize
that we have not formally eliminated the possibility that these cells
(or indeed cardiac tissue in general) express multiple
Na+ channel isoforms. This will require cloning
experiments that are far beyond the scope of the present
experiments. However, the multiple lines of evidence cited above
strongly support the idea that the change in phenotype we
observe is unlikely to be attributable to a switch in expression of
multiple Na+ channel
isoforms.
Intracellular Signaling and INa
Maturation
Our own data and those of others1 2 3 make it
clear that activation of an intracellular signaling event also promotes
the development of a mature INa
phenotype. However, the relationship between activation of
intracellular signaling and the
-ß1
interaction that we have now demonstrated is not clear. One obvious
possibility is that activation of intracellular signaling promotes
increased transcription of the ß1 subunit.
Indeed, we find that mRNA encoding the ß1
subunit is near absent in the neonatal rat heart and increases
dramatically postnatally. However, we have also found that exposure of
AT-1 cells to CPT cAMP from days 0 to 3 in culture does not alter
ß1 mRNA abundance, indicating that increased
ß1 expression cannot be invoked as a major link
between the phenotype switch and activation of intracellular
signaling. Other possibilities that may explain the relationship
between intracellular signaling and the
-ß1
interaction include promotion of translation by a signaling event,
expression of a translation inhibitor in the absence of
activated intracellular signaling, promotion or hindrance of
steric interactions between
and ß1 subunits
during assembly or at the cell membrane by the presence of
phosphorylated residues, and promotion of stability of
a
-ß1 complex by an intracellular signaling
event. The necessity for both ß1 expression and
an intracellular signaling event is further reinforced by the fact that
the ß-adrenergic signaling cascade in cardiac myocytes only matures
around birth,28 and sympathetic innervation of
the heart occurs in the immediate postnatal
period.29 Thus, during development, a mature
INa phenotype must reflect both
cardiac sympathetic innervation, a mature ß-adrenergic signaling
cascade, and expression, translation, assembly, and transport to the
cell surface of ß1 (and
) subunits. Our data
raise the possibility that disruption of the interaction among these
steps may be a crucial event not only in the prevention of a mature
INa phenotype during development
but also in the development of abnormal INa
in acquired cardiac disease.
| Acknowledgments |
|---|
| Footnotes |
|---|
Correspondence to Dan M. Roden, MD, Director, Division of Clinical Pharmacology, 532 Medical Research Building, Vanderbilt University School of Medicine, Nashville, TN 37232-6602.
Received January 20, 1998; accepted June 2, 1998.
| References |
|---|
|
|
|---|
2.
Lipka LJ, Siegelbaum SA, Robinson RB, Berman MF. An
analogue of cAMP mimics developmental change in neonatal rat
ventricular myocyte sodium current kinetics. Am
J Physiol. 1996;270:H194H199.
3.
Yang T, Roden DM. Regulation of sodium current
development in cultured atrial tumor myocytes (AT-1 cells).
Am J Physiol. 1996;271:H541H547.
4.
Field LJ. Atrial natriuretic factor-SV40 T
antigen transgenes produce tumors and cardiac arrhythmias in
mice. Science. 1988;239:10291033.
5.
Steinhelper ME, Lanson NA Jr, Dresdner KP, Delcarpio
JB, Wit AL, Claycomb WC, Field LJ. Proliferation in vivo and
in culture of differentiated adult atrial cardiomyocytes
from transgenic mice. Am J Physiol. 1990;259:H1826H1834.
6.
Delcarpio JB, Lanson NA Jr, Field LJ, Claycomb WC.
Morphological characterization of cardiomyocytes isolated
from a transplantable cardiac tumor derived from transgenic mouse atria
(AT-1 cells). Circ Res. 1991;69:15911600.
7.
Lanson NA, Glembotski CC, Steinhelper ME, Field LJ,
Claycomb WC. Gene expression and atrial natriuretic factor
processing and secretion in cultured AT-1 cardiac myocytes.
Circulation. 1992;85:18351841.
8.
Yang T, Wathen MS, Felipe A, Tamkun MM, Snyders DJ,
Roden DM. K+ currents and
K+ channel mRNA in cultured atrial cardiac
myocytes (AT-1 cells). Circ Res. 1994;75:870878.
9.
Isom LL, De Jongh KS, Patton DE, Reber BFX, Offord J,
Charbonneau H, Walsh K, Goldin AL, Catterall WA. Primary structure and
functional expression of the ß1 subunit of the
rat brain sodium channel. Science. 1992;256:839842.
10. Kupershmidt S, Yang T, Roden DM. Inhibition of beta-subunit expression prevents development of a mature sodium current phenotype in cultured heart cells [abstract]. Circulation. 1996;94(suppl I):I-287I-287.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1989.
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156159.[Medline] [Order article via Infotrieve]
13.
Balser JR, Bennett PB, Roden DM. Time-dependent outward
current in guinea pig ventricular myocytes: gating kinetics
of the delayed rectifier. J Gen Physiol. 1990;96:835863.
14.
Makita N, Bennett PB Jr, George AL Jr. Voltage-gated
Na+ channel ß1 subunit
mRNA expressed in adult human skeletal muscle, heart, and brain is
encoded by a single gene. J Biol Chem. 1994;269:75717578.
15.
Qu Y, Isom LL, Westenbroek RE, Rogers JC, Tanada TN,
McCormick KA, Scheuer T, Catterall WA. Modulation of cardiac
Na+ channel expression in Xenopus oocytes by
ß1 subunits. J Biol Chem. 1995;270:2569625701.
16.
Nuss HB, Chiamvimonvat N, Pérez-García
MT, Tomaselli GF, Marban E. Functional association of the ß1
subunit with human cardiac (hH1) and rat skeletal muscle (µ1) sodium
channel
subunits expressed in Xenopus oocytes.
J. Gen. Physiol. 1995;106:11711191.
17. Isom LL, Catterall WA. Na+ channel subunits and Ig domains. Nature. 1996;383:307308.[Medline] [Order article via Infotrieve]
18.
Isom LL, Scheuer T, Brownstein AB, Ragsdale DS, Murphy
BJ, Catterall WA. Functional co-expression of the beta 1 and type IIA
alpha subunits of sodium channels in a mammalian cell line.
J Biol Chem. 1995;270:33063312.
19.
Lue WM, Boyden PA. Abnormal electrical properties of
myocytes from chronically infarcted canine heart: alterations in Vmax
and the transient outward current. Circulation. 1992;85:11751188.
20.
Feng JL, Wible B, Li G-R, Wang Z, Nattel S. Antisense
oligodeoxynucleotides directed against Kv1.5 mRNA
specifically inhibit ultrarapid delayed rectifier
K+ current in cultured adult human atrial
myocytes. Circ Res. 1997;80:572579.
21. Roy ML, Saal D, Perney T, Sontheimer H, Waxman SG, Kaczmarek LK. Manipulation of the delayed rectifier Kv1.5 potassium channel in glial cells by antisense oligodeoxynucleotides. Glia. 1996;18:177184.[Medline] [Order article via Infotrieve]
22.
Chung S, Saal DB, Kaczmarek LK. Elimination of
potassium channel expression by antisense
oligonucleotides in a pituitary cell line. Proc
Natl Acad Sci U S A.. 1995;92:59555959.
23. Wagner JA, McDonald TV, Nghiem PT, Lowe AW, Schulman H, Gruenert DC, Stryer L, Gardner P. Antisense oligodeoxynucleotides to the cystic fibrosis transmembrane conductance regulator inhibit cAMP-activated but not calcium-activated chloride currents. Proc Natl Acad Sci U S A. 1992;89:67856789.
24.
Yang T, Kupershmidt S, Roden DM. Anti-minK antisense
decreases the amplitude of the rapidly activating cardiac delayed
rectifier K+ current. Circ Res. 1995;77:12461253.
25. McDonald TV, Yu Z, Ming Z, Palma E, Meyers MB, Wang KW, Goldstein, SA, Fishman GI. A minK-HERG complex regulates the cardiac potassium current I(Kr). Nature. 1997;388:289292.[Medline] [Order article via Infotrieve]
26. Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature. 1994;372:333335.[Medline] [Order article via Infotrieve]
27. Ghosh MK, Cohen JS. Oligodeoxynucleotides as antisense inhibitors of gene expression. Prog Nucleic Acid Res Mol Biol. 1992;42:79126.[Medline] [Order article via Infotrieve]
28.
An RH, Davies MP, Doevendans PA, Kubalak SW, Bangalore
R, Chien KR, Kass RS. Developmental changes in ß-adrenergic
modulation of L-type Ca2+ channels in embryonic
mouse heart. Circ Res. 1996;78:371378.
29.
Sun LS, Legato MJ, Rosen TS, Steinberg SF, Rosen MR.
Sympathetic innervation modulates ventricular impulse
propagation and repolarization in the immature rat heart.
Cardiovasc Res. 1993;27:459463.
This article has been cited by other articles:
![]() |
V. Haufe, J.M. Cordeiro, T. Zimmer, Y.S. Wu, S. Schiccitano, K. Benndorf, and R. Dumaine Contribution of neuronal sodium channels to the cardiac fast sodium current INa is greater in dog heart Purkinje fibers than in ventricles Cardiovasc Res, January 1, 2005; 65(1): 117 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Probst, F. Kyndt, F. Potet, J.-N. Trochu, G. Mialet, S. Demolombe, J.-J. Schott, I. Baro, D. Escande, and H. Le Marec Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenegre disease J. Am. Coll. Cardiol., February 19, 2003; 41(4): 643 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R Bezzina, M. B Rook, and A. A.M Wilde Cardiac sodium channel and inherited arrhythmia syndromes Cardiovasc Res, February 1, 2001; 49(2): 257 - 271. [Full Text] [PDF] |
||||
![]() |
C. Bezzina, M. W. Veldkamp, M. P. van den Berg, A. V. Postma, M. B. Rook, J.-W. Viersma, I. M. van Langen, G. Tan-Sindhunata, M. Th. E. Bink-Boelkens, A. H. van der Hout, et al. A Single Na+ Channel Mutation Causing Both Long-QT and Brugada Syndromes Circ. Res., December 3, 1999; 85(12): 1206 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Rook, C. Bezzina Alshinawi, W.A. Groenewegen, I. C. van Gelder, A. C.G. van Ginneken, H. J. Jongsma, M. M.A.M. Mannens, and A. A.M. Wilde Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome Cardiovasc Res, December 1, 1999; 44(3): 507 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Roden and S. Kupershmidt From genes to channels: normal mechanisms Cardiovasc Res, May 1, 1999; 42(2): 318 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Balser Structure and function of the cardiac sodium channels Cardiovasc Res, May 1, 1999; 42(2): 327 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C Makielski, J. Limberis, Z. Fan, and J. W Kyle Intrinsic lidocaine affinity for Na channels expressed in Xenopus oocytes depends on {alpha} (hH1 vs. rSkM1) and {beta}1 subunits Cardiovasc Res, May 1, 1999; 42(2): 503 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Zimmer, C. Bollensdorff, V. Haufe, E. Birch-Hirschfeld, and K. Benndorf Mouse heart Na+ channels: primary structure and function of two isoforms and alternatively spliced variants Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1007 - H1017. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |